Cancer incidence and mortality do not fully reflect the effect of cancer. To estimate the number of persons alive who have a history of cancer, we derived prevalence rates based on data from the Connecticut Tumor Registry. We did not attempt to distinguish between people who had been cured of cancer and those who still had the disease. In 1982 the age-adjusted prevalence rates of cancer among males and females were 1,789 and 2,222, respectively, per 100,000. Age-specific prevalence rates were highest among the elderly; 12 percent of men and 11 percent of women over 70 had previously been given a diagnosis of cancer. Breast cancer in females and prostate cancer in males were the two most prevalent malignant diseases. We estimate that about 5 million persons alive in the United States today have at one time received a diagnosis of cancer.
This article has been cited by other articles:
Mariotto, A. B., Rowland, J. H., Ries, L. A.G., Scoppa, S., Feuer, E. J.
(2007). Multiple Cancer Prevalence: A Growing Challenge in Long-term Survivorship. Cancer Epidemiol. Biomarkers Prev.
16: 566-571
[Abstract][Full Text]
Gigli, A., Mariotto, A., Clegg, L. X, Tavilla, A., Corazziari, I., Capocaccia, R., Hachey, M., Scoppa, S.
(2006). Estimating the variance of cancer prevalence from population-based registries. Stat Methods Med Res
15: 235-253
[Abstract]
Naumov, G. N., Bender, E., Zurakowski, D., Kang, S.-Y., Sampson, D., Flynn, E., Watnick, R. S., Straume, O., Akslen, L. A., Folkman, J., Almog, N.
(2006). A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype.. JNCI J Natl Cancer Inst
98: 316-325
[Abstract][Full Text]
Li, M., Ng, S. S.-m., Wang, J., Lai, L., Yi Leung, S., Franco, M., Peng, Y., He, M.-l., Kung, H.-f., Lin, M. C.-m.
(2006). EFA6A Enhances Glioma Cell Invasion through ADP Ribosylation Factor 6/Extracellular Signal-Regulated Kinase Signaling. Cancer Res.
66: 1583-1590
[Abstract][Full Text]
Castro, M. R., Gharib, H.
(2005). Continuing Controversies in the Management of Thyroid Nodules. ANN INTERN MED
142: 926-931
[Abstract][Full Text]
Gras, C, Daures, J P, Tretarre, B
(2004). Age and stage specific prevalence estimate of cancer from population based Cancer Registry using inhomogeneous Poisson process. Stat Methods Med Res
13: 273-289
[Abstract]
Kunapuli, P., Kasyapa, C. S., Hawthorn, L., Cowell, J. K.
(2004). LGI1, a Putative Tumor Metastasis Suppressor Gene, Controls in Vitro Invasiveness and Expression of Matrix Metalloproteinases in Glioma Cells through the ERK1/2 Pathway. J. Biol. Chem.
279: 23151-23157
[Abstract][Full Text]
Swensen, S. J., Jett, J. R., Hartman, T. E., Midthun, D. E., Sloan, J. A., Sykes, A.-M., Aughenbaugh, G. L., Clemens, M. A.
(2003). Lung Cancer Screening with CT: Mayo Clinic Experience. Radiology
226: 756-761
[Abstract][Full Text]
Herman, C. R., Gill, H. K., Eng, J., Fajardo, L. L.
(2002). Screening for Preclinical Disease: Test and Disease Characteristics. Am. J. Roentgenol.
179: 825-831
[Full Text]
Swensen, S. J.
(2002). CT Screening for Lung Cancer. Am. J. Roentgenol.
179: 833-836
[Full Text]
Capocaccia, R., Colonna, M., Corazziari, I., De Angelis, R., Francisci, S., Micheli, A., Mugno, E.
(2002). Measuring cancer prevalence in Europe: the EUROPREVAL Project. Ann Oncol
13: 831-839
[Abstract][Full Text]
Micheli, A., Mugno, E., Krogh, V., Quinn, M. J., Coleman, M., Hakulinen, T., Gatta, G., Berrino, F., Capocaccia, R., the EUROPREVAL Working Group,
(2002). Cancer prevalence in European registry areas. Ann Oncol
13: 840-865
[Abstract][Full Text]
Stanley, R. J.
(2001). Inherent Dangers in Radiologic Screening. Am. J. Roentgenol.
177: 989-992
[Full Text]
Davis, F. G., Kupelian, V., Freels, S., McCarthy, B., Surawicz, T.
(2001). Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol
3: 152-158
[Abstract]
Merrill, R M
(2001). Partitioned prostate cancer prevalence estimates: an informative measure of the disease burden. J. Epidemiol. Community Health
55: 191-197
[Abstract][Full Text]
Merrill, R. M, Capocaccia, R., Feuer, E. J, Mariotto, A.
(2000). Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. Int J Epidemiol
29: 197-207
[Abstract][Full Text]
Chung Sun, E., Curtis, R., Melbye, M., Goedert, J. J.
(1999). Salivary Gland Cancer in the United States. Cancer Epidemiol. Biomarkers Prev.
8: 1095-1100
[Abstract][Full Text]
Hewitt, M., Breen, N., Devesa, S.
(1999). Cancer Prevalence and Survivorship Issues: Analyses of the 1992 National Health Interview Survey. JNCI J Natl Cancer Inst
91: 1480-1486
[Abstract][Full Text]
Feuer, E. J., Merrill, R. M., Hankey, B. F.
(1999). Cancer Surveillance Series: Interpreting Trends in Prostate Cancer—Part II: Cause of Death Misclassification and the Recent Rise and Fall in Prostate Cancer Mortality. JNCI J Natl Cancer Inst
91: 1025-1032
[Abstract][Full Text]
Farley, M. M., Harvey, C., Stull, T., Smith, J. D., Schuchat, A., Wenger, J. D., Stephens, D. S.
(1993). A Population-Based Assessment of Invasive Disease Due to Group B Streptococcus in Nonpregnant Adults. NEJM
328: 1807-1811
[Abstract][Full Text]
Black, W. C., Welch, H. G.
(1993). Advances in Diagnostic Imaging and Overestimations of Disease Prevalence and the Benefits of Therapy. NEJM
328: 1237-1243
[Full Text]
Previous
